Asif Azeem, MD
Gastroenterology · Grand Rapids, MINPI 1932288248
Payments from drug & device makers
Across 439 payments — averaging $16.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Johnson & Johnson$1K
- Takeda Pharmaceuticals U.S.A., Inc.$953
- Braintree Laboratories, Inc.$623
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$369
- Merck$353
- plus $2K from 28 others
What the payments were for
- Food & beverage$6,69995%
- Education$911%
- Gifts$2353%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 112 | $1,532 |
| Johnson & Johnson | 69 | $1,073 |
| Takeda Pharmaceuticals U.S.A., Inc. | 62 | $953 |
| Braintree Laboratories, Inc. | 26 | $623 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 25 | $369 |
| Merck | 21 | $353 |
| Bristol Myers Squibb | 24 | $274 |
| Gilead | 10 | $205 |
| Intercept Pharmaceuticals, Inc. | 12 | $192 |
| Pfizer | 7 | $128 |
| Lilly USA, LLC | 6 | $123 |
| Ironwood Pharmaceuticals, Inc | 6 | $109 |
| Sanofi | 5 | $100 |
| Madrigal Pharmaceuticals | 4 | $98 |
| Shionogi Inc | 6 | $96 |
| Regeneron Healthcare Solutions, Inc. | 4 | $93 |
| Daiichi Sankyo Inc. | 6 | $91 |
| Nestle Healthcare Nutrition Inc. | 4 | $73 |
| Celltrion USA Inc. | 3 | $65 |
| Sandoz | 3 | $63 |
| UCB, Inc. | 3 | $49 |
| Ipsen Biopharmaceuticals, Inc | 2 | $45 |
| Fresenius Kabi USA, LLC | 2 | $43 |
| AstraZeneca | 3 | $42 |
| Ardelyx, Inc. | 2 | $38 |
| Aimmune Therapeutics, Inc. | 2 | $37 |
| Ferring Pharmaceuticals Inc. | 2 | $30 |
| E.r. Squibb & Sons, L.L.C. | 1 | $27 |
| Novo Nordisk | 1 | $22 |
| Mylan Institutional Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 2 | $18 |
| Alnylam Pharmaceuticals Inc. | 1 | $15 |
| Olympus America Inc. | 1 | $14 |
| Shire North American Group Inc | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Tremfya$147
How this compares
$7,025 in reported general payments places this provider in the 70th percentile of 497 gastroenterology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| XifaxanRifaximin | 11 | $34,044 |
| Mesalamine | 13 | $10,677 |
| LinzessLinaclotide | 11 | $9,701 |
| Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg | 257 | $6,369 |
| Budesonide DrBudesonide | 28 | $4,280 |
| Omeprazole | 79 | $1,804 |
| Lansoprazole | 12 | $838 |
| Lactulose | 18 | $602 |
| Azathioprine | 23 | $589 |
| Pantoprazole Sodium | 21 | $523 |
| Amitriptyline Hcl | 45 | $510 |
| Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl | 15 | $468 |
| Esomeprazole Magnesium | 14 | $153 |
| Spironolactone | 11 | $142 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $369 | $34,04411 claims |
| AbbVieLinzess | $1,532 | $9,70111 claims |
| SandozLansoprazole | $63 | $83812 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 497 gastroenterology providers in Michigan.
Other gastroenterology in Grand Rapids
- Jeremy BarberGrand Rapids$109K
- Andrew ShreinerGrand Rapids$65K
- Allan CoatesWyoming$5.9M
- Ronald FogelChesterfield$5.1M
- Stuart GordonDetroit$4.3M
- Jeffery BerinsteinAnn Arbor$3.3M
- Najm SoofiYpsilanti$2.6M
- Peter HigginsAnn Arbor$2.4M
- Partha NandiTroy$1.4M
- Frederick AskariAnn Arbor$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.